Identification of mutations in Colombian patients affected with Fabry disease

Alfredo Uribe, Heidi Eliana Mateus, Juan Carlos Prieto, Maria Fernanda Palacios, Sandra Yaneth Ospina, Gabriela Pasqualim, Ursula da Silveira Matte, Roberto Giugliani

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

7 Citas (Scopus)


Fabry Disease (FD) is an X-linked inborn error of glycosphingolipid catabolism, caused by a deficiency of the lisosomal α-galactosidase A (AGAL). The disorder leads to a vascular disease secondary to the involvement of kidney, heart and the central nervous system. The mutation analysis is a valuable tool for diagnosis and genetic counseling. Although more than 600 mutations have been identified, most mutations are private. Our objective was to describe the analysis of nine Colombian patients with Fabry disease by automated sequencing of the seven exons of the GLA gene. Two novel mutations were identified in two patients affected with the classical subtype of FD, in addition to other 6 mutations previously reported. The present study confirms the heterogeneity of mutations in Fabry disease and the importance of molecular analysis for genetic counseling, female heterozygotes detection as well as therapeutic decisions.
Idioma originalInglés estadounidense
Número de artículo40764
Páginas (desde-hasta)325-329
Número de páginas5
EstadoPublicada - dic. 15 2015

Áreas temáticas de ASJC Scopus

  • Genética


Profundice en los temas de investigación de 'Identification of mutations in Colombian patients affected with Fabry disease'. En conjunto forman una huella única.

Citar esto